HK1203935A1 - Azetidine and piperidine compounds useful as pde10 inhibitors - Google Patents

Azetidine and piperidine compounds useful as pde10 inhibitors Download PDF

Info

Publication number
HK1203935A1
HK1203935A1 HK15104351.8A HK15104351A HK1203935A1 HK 1203935 A1 HK1203935 A1 HK 1203935A1 HK 15104351 A HK15104351 A HK 15104351A HK 1203935 A1 HK1203935 A1 HK 1203935A1
Authority
HK
Hong Kong
Prior art keywords
azetidine
piperidine compounds
compounds useful
pde10 inhibitors
pde10
Prior art date
Application number
HK15104351.8A
Other languages
English (en)
Chinese (zh)
Inventor
Jennifer R. Allen
Jian J. Chen
Michael J. Frohn
Matthew Richard KALLER
Qingyian Liu
Thomas T. Nguyen
Alexander J. Pickrell
Wenyuan Qian
Robert M. Rzasa
Wenge Zhong
Original Assignee
Amgen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48692687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1203935(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen, Inc. filed Critical Amgen, Inc.
Publication of HK1203935A1 publication Critical patent/HK1203935A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
HK15104351.8A 2012-06-14 2013-06-14 Azetidine and piperidine compounds useful as pde10 inhibitors HK1203935A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659911P 2012-06-14 2012-06-14
US61/659,911 2012-06-14
PCT/US2013/045768 WO2013188724A1 (en) 2012-06-14 2013-06-14 Azetidine and piperidine compounds useful as pde10 inhibitors

Publications (1)

Publication Number Publication Date
HK1203935A1 true HK1203935A1 (en) 2015-11-06

Family

ID=48692687

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104351.8A HK1203935A1 (en) 2012-06-14 2013-06-14 Azetidine and piperidine compounds useful as pde10 inhibitors

Country Status (25)

Country Link
US (3) US8691986B2 (cg-RX-API-DMAC7.html)
EP (1) EP2864317A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015519402A (cg-RX-API-DMAC7.html)
KR (1) KR20150023417A (cg-RX-API-DMAC7.html)
CN (1) CN104619694A (cg-RX-API-DMAC7.html)
AP (1) AP2014008136A0 (cg-RX-API-DMAC7.html)
AR (1) AR091436A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013274153B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014031368A2 (cg-RX-API-DMAC7.html)
CA (1) CA2875802A1 (cg-RX-API-DMAC7.html)
CL (1) CL2014003391A1 (cg-RX-API-DMAC7.html)
CO (1) CO7160011A2 (cg-RX-API-DMAC7.html)
CR (1) CR20150012A (cg-RX-API-DMAC7.html)
EA (1) EA201590014A1 (cg-RX-API-DMAC7.html)
HK (1) HK1203935A1 (cg-RX-API-DMAC7.html)
IL (1) IL235901A0 (cg-RX-API-DMAC7.html)
MA (1) MA37748B1 (cg-RX-API-DMAC7.html)
MX (1) MX2014014924A (cg-RX-API-DMAC7.html)
PE (1) PE20150348A1 (cg-RX-API-DMAC7.html)
PH (1) PH12014502780A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201408168UA (cg-RX-API-DMAC7.html)
TN (1) TN2014000510A1 (cg-RX-API-DMAC7.html)
TW (1) TWI508959B (cg-RX-API-DMAC7.html)
UY (1) UY34858A (cg-RX-API-DMAC7.html)
WO (1) WO2013188724A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103221404B (zh) 2010-05-13 2015-12-16 安姆根有限公司 可用作pde10抑制剂的不饱和氮杂环化合物
AR091436A1 (es) * 2012-06-14 2015-02-04 Amgen Inc Compuestos de azetidina y piperidina utiles como inhibidores de pde10

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
CN103221404B (zh) 2010-05-13 2015-12-16 安姆根有限公司 可用作pde10抑制剂的不饱和氮杂环化合物
CA2800578A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Nitrogen-heterocyclic compounds as phosphodiesterase 10 inhibitors
EP2569302A1 (en) * 2010-05-13 2013-03-20 Amgen, Inc Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
US8952037B2 (en) * 2010-05-13 2015-02-10 Amgen Inc. Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
AR091436A1 (es) * 2012-06-14 2015-02-04 Amgen Inc Compuestos de azetidina y piperidina utiles como inhibidores de pde10

Also Published As

Publication number Publication date
AU2013274153A1 (en) 2014-12-18
EA201590014A1 (ru) 2015-04-30
JP2015519402A (ja) 2015-07-09
WO2013188724A1 (en) 2013-12-19
MA37748A1 (fr) 2016-11-30
US20140148435A1 (en) 2014-05-29
MX2014014924A (es) 2015-03-09
CO7160011A2 (es) 2015-01-15
TN2014000510A1 (en) 2016-03-30
TW201412729A (zh) 2014-04-01
US8691986B2 (en) 2014-04-08
US9303028B2 (en) 2016-04-05
PE20150348A1 (es) 2015-03-04
PH12014502780A1 (en) 2015-02-02
UY34858A (es) 2013-11-29
CR20150012A (es) 2015-02-11
US20130338138A1 (en) 2013-12-19
AR091436A1 (es) 2015-02-04
MA37748B1 (fr) 2017-07-31
AP2014008136A0 (en) 2014-12-31
BR112014031368A2 (pt) 2017-06-27
US9493459B2 (en) 2016-11-15
CL2014003391A1 (es) 2015-07-10
AU2013274153B2 (en) 2016-05-19
SG11201408168UA (en) 2015-01-29
IL235901A0 (en) 2015-09-24
KR20150023417A (ko) 2015-03-05
CA2875802A1 (en) 2013-12-19
CN104619694A (zh) 2015-05-13
EP2864317A1 (en) 2015-04-29
TWI508959B (zh) 2015-11-21
US20160176874A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
PH12012502212A1 (en) Nitrogen heterocyclic compounds usefulas pde10 inhibitors
CA2871471C (en) Dna-pk inhibitors
WO2014152965A3 (en) Schizophrenia-associated genetic loci identified in genome wide association studies and use thereof as novel therapeutic targets
MX347917B (es) Compuestos a base de imidazo[1,2-b]piridazina, composiciones que los comprenden, y metodos para su uso.
WO2014106238A8 (en) Heterocyclic compounds and methods of use thereof
TN2011000221A1 (en) Pyrazine compounds as phosphodiesterase 10 inhibitors
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
MX2013012776A (es) Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina.
TN2011000220A1 (en) Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
WO2014031438A3 (en) SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
MX357502B (es) Derivados de pirrolotriazinona.
WO2011132051A3 (en) Tricycle compounds as phosphodiesterase-10 inhibitors
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
WO2013040227A3 (en) Therapeutic compounds
GB201114389D0 (en) Novel compounds
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
PH12015501052A1 (en) Solid form of dihydro-pyrido-oxazine drivative
PH12014502780A1 (en) Azetidine and piperidine compounds useful as pde10 inhibitors
WO2010129848A3 (en) 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
AU2012312301A8 (en) Compounds useful as inhibitors of choline kinase
HK1176618A (en) Nitrogen heterocyclic compounds useful as pde10 inhibitors
HK1170670A (en) Compositions and methods for inhibition of the jak pathway
HK1205937A1 (en) Difluorolactam compositions for ep4-mediated osteo related diseases and conditions
HK1203954A1 (en) Heteroaryl compounds and methods of use thereof